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INTRODUCTION 
Snakes  are  a  fascinating  part  of  nature.  Their  color,  movement  and  
secretive  habits  make  them  more  mysterious  than other  animals.  There  are  over  
300  species  of  snakes  in  the world, of  which  more  than  200  ranging  in  size  
from  100 mm. Long  worm  snakes  to  6 m  long  pythons  are  found  in  India.1 
 
In  India  snakes  have  been  worshipped  as  gods  for  thousands  of  years.  
Even  today  in  Maharashtra  during  the  harvest  festival  called  “nagapanchami”  
freshly  caught  cobras  are worshipped  with  flower,  ghee  and  money.  Most  of  us  
flee  at  the site  of  a  snake.  However  group  of  people  have  based  their  living  on  
these  primitive  reptiles. 
   
In  south  India,  the  irula  tribal’s  over  years  have  been  supplying  millions  
of  snake  skins  for  export.  As  this  trade  has been  banned  today.  They  catch  
snakes  for  venom  extraction  and this  venom  is  then  used  in  the  process  of  
antivenom  production.2 
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Snake  bite  is  a  common  emergency  encountered  in  day  to day  practice.  
Morbidity  and  mortality  due  to  snakebite  is  a preventable  health  hazard  in  the  
tropical  and  subtropical  countries. 
 
In  India  due  to  the  prevailing  climatic  conditions  and  due to  the  fact  that  
a  major  portion  of  the  population  is  rural  and agrarian,  snakebite  is  a  major  
health  problem.3 
 
Every  year  15,000  die  out  of  2,00,000  snake  bites  in  India. The  death  
rate  is  approximately  1.5%.  However  this  figure  is  based  on  hospital  statistics  
whereas  in  practice  most  rural  patients prefer  treatment  by  traditional  healer  and  
do  not  go  to  hospitals. 
 
 Dr. Patrick  Russell  in  1976  work  from,  “India  of  snake bites”.  The  
progress  of  disease  and  succession  of  symptoms,  had either  not  been  attended  to  
or  were  indistinctly  recollected.  His plea  for  the  clinical  observation  remained  
largely  unheeded  for years  until  the  landmark  study  in  1963  by  Reid.4 
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 It  is  a  fact  the  effect  of  cobra  bite  kills  the  patient  within minutes  to  
hours,  if  managed  sufficiently  early  with  antisnake venom,  the  patient  recovers  
soon.  In  the  cases  viper  bites,  which are  more  common,  death  occurs  over  days.  
Even  in  the  absence of  death,  the  morbidity  is  high.  These  factors  necessitate 
aggressive  and  specific  treatment.5 
 
The  effect  of  snake  bites  on  the  various  body  systems  and their  
management  still  holds  a  lot  of  controversy.  We  have chosen  a  study  on  these  
clinical  and  prognostic  profile  and response  to  treatment  as  our  institute  is  
situated  in  a  primarily  rural  setting.  With  high  inflow  of  cases,  mainly  viper  
bites  occurs. 
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AIMS OF STUDY 
1.  To  document  the  local  species  of  snakes  that  commonly  cause  various  
clinical features. 
2.  To  analyze  the  time  interval  between  the  snakebite  and  the  onset of  various 
clinical  features. 
3.  To  find  the  correlation  between  the  clinical  profile  and  the  time interval  
between  bite  and  starting  of  treatment. 
4.  To  correlate  the  clinical  severity  to  the  complications  encountered  by 
quantitative  coagulation  and  renal  function  test. 
5.  To  study  the  time  taken  for  reversal  of  changes  in  clinical  profile  following 
ASV  therapy. 
6.  To  document  the  incidence  of  compartment  syndrome  and  the  prognosis  of 
the  patients  with  and  without  fasciotomy. 
7.  To  analyze  the  complications  of  ASV  therapy. 
8.  To  study  the  time  interval  between  the  administration  of  ASV. 
9. To  study  cardiovascular  and  neurological  manifestations  of  snake  bite 
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REVIEW  OF  LITERATURE 
“An  important  phase  of  medicine  is  the  ability  to  appraise  the  literature 
correctly”  -  Hippocrates 
 
TAXONOMY,  IDENTIFICATION  AND  DISTRIBUTION  OF  SNAKES 
There  are  about  2500 – 3000  snake  species,  of  which  500  belongs  to  five 
families  of  venomous  snake.  In  India  there  are  236  snake  species,  among  them 
50  are  poisonous.  Among  non  venomous  some  are  potentially  dangerous  they 
are  South  African  and  Asian  pythons  and  the  south  American  anaconda. 
 
Poisonous  snake  prevalent  in  India  among  four  families.  They  are 
1. Elapidae  –  includes  cobras  and  krait 
2. Viperidae  (true  viper)  –  includes  russell’s  and  saw  scaled  viper 
3. Colubridae  (pit  viper)  -  includes  green  pit  viper 
4. Hydrophidae  or  sea  snakes5  
In  India  although  they  are  venomous,  they  are  not  threat  to  man. 
 
The  only  venomous  snakes  to  be  wary  of  the  “big  four” -  cobra,  krait,  
Russell viper,  saw  scaled  viper.2 
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COBRAS 
Two  species  are  found  in  India  common  cobra  (Naja naja)  and  king cobra  
(ophiophagus hannah).  Cobras  vary  in  color  from  black  or  dark  brown  to  yellow 
white.  The  head  is  indistinct  from  the  neck  and  the  ribs  in  the  region  is 
movable  and  expand  to  form  the  hood.  The  hood  resembles  a  spectacle  
showing  a  pair  of  rings.  They  are  confused  with  Indian  rat,  snakes  with  thin 
neck  and  head  and  3  meters  longer  than  Indian  cobras (sara  pambu).  King 
cobras  live  in  dense  forest  and  grow  upto  18  feet.  They  are  usually  black  in 
color. 
 
KRAIT 
Two  species  are  common  in  India  common  krait (kattu  viriyan)  and 
banded  krait  (pattai  kattuviriyan).  Common  krait  is  steel  blue  or  black  with 
white  bars  on  the  back.  Banded  krait  is  larger  and  is  jet  black  in  color  with 
yellow  bars.  Kraits  are  usually  found  in  pairs 
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SAW  SCALED  VIPER 
A  small  snake  (30cm  long)  with  brown  or  greyish  dorsum  showing  
zigzag  pattern.  It  has  a  distinct  cross  or  lance  mark  on  the  head.  The  ventral 
scales  are  rough.  They  produce  a  rasping  soundby  rubbing  their  coils  together. 
This  snake  is  confused  with  non  poisonous  cat  snake  which  has  a  long  tail, 
prominent  eyes  and  a  clear  Y  mark  in  head.   
 
Most  often  a  killed  snake  is brought  by  the  patient  and  the  physician  has  
to  identify  whether  poisonous  or not. If  the  physician  has  a  mental  picture  of  
the  four common  poisonous  snakes  it  would  be  much  easier  for  him  to  know  
which  bite has  to  be  given  significance. 
 
 
 
 
 
 
 
19 
 
DIFFERENCE BETWEEN VENOMOUS AND NON-VENOMOUS SNAKES 
Features Venomous Snakes Non-Venomous Snakes 
Poison 
Apparatus 
                           Present Absent 
Saliva Toxic, contains toxic peptides and 
enzymes 
Non toxic 
Tail Compressed Rounded 
 Belly Scales Broad, extends across entire width of 
the body 
Small and never extends 
across  the body 
Back Scales Enlarged Not enlarged 
Head Scales Usually smaller, when larger it 
possess special features like a pit, 
supra labial scale, infra labial shield 
Usually larger with no 
special features 
Teeth 
 
Upper jaw has a pair of teeth 
modified into fangs that are grooved 
All teeth are uniform and 
small in size 
Bite Marks  Usually two More than two 
Habit Mostly nocturnal Not nocturnal 
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VENOM CHARACTERISTICS: 
 
SNAKE 
 
Fatal dose 
Average dose 
delivered per 
bite 
Average fatal 
period 
 
INDIAN COBRA 
 
12mg 
 
0.2g 
 
8hours 
 
COMMON KRAIT 
 
6mg 
 
0.22g 
 
18hours 
 
RUSSELL VIPER 
 
15mg 
 
0.15g 
 
3days 
 
SAW SCALED VIPER 
 
 
8mg 
 
0.13g 
 
41days 
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GENERAL  FACTS  ABOUT  SNAKES 
Snakes  are  cold  blooded  animals  without  tympanic  membrane.  They  react  to 
vibrations  received  through  the  surface  on  which  they  rest  rather  than  air  borne 
vibrations.  Snakes  do  not  have  a  distinct  visual  system  and  they  do  not  readily 
associate  stationary  objects  with  danger.  Their  sense  of  smell  is  the  most 
important.  Most  land  snakes  feed  on  mice,  rats  and  frogs.  Krait  and  cobras  are 
exceptional  in  being  mainly  snake  eaters1. The  life  span  of  snakes  in  the  wild  has  
not  been  established.  Longevity  of  some  Indian  snakes  kept  in  zoos  and  by  
individuals include  Indian  python  - 34  years,  banded  kraits - 11 years,  Indian  cobra - 
21 years, saw  scaled  viper - 10 years.  
 
EPIDEMIOLOGICAL  FEATURES  OF  SNAKE  BITE: 
Documented  reports  of  epidemiological  studies  of  snake  bite  in  India  are 
few.  Although  the  exact  number  of  persons  inflicted  by  snake  bite  is  not 
known,  it  is  estimated  that  about  2,00,000  persons  are  annually  bitten  by  snakes 
in  the  country  and  15,000  of  these  are  fatal.6  In  a  study  conducted  in  
Tamilnadu,  hospitals  records  showed  a  mortality  of  11.6 %.  According  to  study 
by  sawai  in  1974,  71 %  of  the  victims  are  found  in  the  age  group  of  11 - 50 
years  and  75 %  victims  are  males.7  A  Safdarjung  hospital  study  showed  81.5 % 
of  victims  to  be  field  workers. 75 %  bite  occurred   outdoors,   88.6%  of  victims 
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were   from   rural   india.   Incidence   of   snake   bite  in  India  shows  a  seasonal 
variation.  In  north  India  70-80%  of  bites  are  seen  in  the  warmer  months  may 
be  October  6,  while  a   study  conducted  in  Calicut  Medical  college,  Kerala 
showed  a  maximum  incidence  in  winter  months  (oct-jan)  with   the   incidence   
of   complications   also   maximum   during   this   period.8   Saiwas   study  in  1974 
showed   68%   of  snake   bites  occurred  in  the  evening and  night,  32%  in  the 
morning   and   afternoon,   72%   of   bites   were  on  the  lower  limbs,  25%  on  the 
hand  and  arm  and  3%  were  on  the  trunk. 
 
VENOM  APPARATUS  AND  COMPOSITION: 
               In  certain  snake  the  paired  salivary  gland  has  assumed  a  very 
significant  function  (venom  apparatus).6  They  secrete  venom,  a  powerful 
multipurpose  enzyme  fluid  through  the  channeled  or  grooved  teeth,  the  fangs. 
Venom  can  be  injected  from  the  bottom  of  the  fang (viper)  or  by  an  opening  at 
the  anterior  aspect  of  the  fang,  a  few  millimeters  above  the  tip.4  Palestine  
vipers in  catching  their  prey  inject  lethal  doses  of  venom  at  each  of  ten  or  
more consecutive  strikes.  When  snakes  have  bitten  two  or  more  humans  in  rapid 
succession,  the  second  or  third  victims  were  sometimes  more  envenomed  than 
the  first.  However  Russell  vipers  appear  to  inject  most  of  their  available  venom 
at  first  strike.  50 %  of  Malayan  pit  viper  bite  showed  little  or  no  envenoming. 
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This  suggests  that  some  snakes  might  be  capable  of   biting  defensively  without 
injecting  venom. 
Snake  venom  is  a  complex  fluid  with  powerful  ingredients  that  act  to 
immobilize  its  prey.  Venom  is  transparent,  yellowish,  slightly  viscous  and  
acidic.  It  is  extremely  heterogeneous  containing  about  15  enzymes  and  10  non 
enzymatic  proteins  and  peptides  and  atleast  a  dozen  of  other  substance.6  Various 
components  of  the  snake  venom  have  been  mentioned  in  the  accompanying 
table.  Deoras  in  1965  reported  the  lethal  dose  of  venom  common  Indian 
poisonous  snake  to  be  cobra - 0.12 g,  Russell  viper - 0.15 g  and  echis  carinatus -
0.08 g.9  Variations  in  venom  composition  from  species  to  species  explains  the 
varied  clinical  presentation  of  snake  bite. 
Hyaluronidase  is  present  in  almost  all  snake  venom.  It  hydrolyzes  the 
hyaluronic  acid  in  interstitial  spaces  of  the  cells  and  connective  tissue  allowing 
further  penetration  venom  into  the  surrounding  tissues.6  Protease  in  viper  venom 
activates  the  mammalian  clotting  cascade  by  activation  of  factor  IX  or  X.  
Ecarin  a  zinc  metalloprotein  activates  prothrombin.4 
Phospholipase  A2  the  extensively  studied  of  all  venom  constituents  has 
damaging  effects  on  RBC,  platelets,  leucocytes,  skeletal  muscle,  endothelium, 
presynaptic  terminals  and  also  has  opiate  like  sedative  effects.4 
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Polypeptides  called  neurotoxins  also  cause  presynaptic  inhibition  by 
blocking  acetylcholine  release  or  post  synaptic  inhibition  blocking  its  action.4 
Hemorrhagins  cause  disruption  of  basement  membrane  of  vessels  and  cause 
bleeding  into  organs.6 
Actions  of  Snake  Venom 
 S. NO. ENZYMES                      ACTIONS   
  1 Acetylcholine  esterase Catalysis and hydrolysis of acetylcholine 
  2 Arginine ester hydrolase Bradykinin release, interfere with clotting 
  3 Hyaluronidase A Reduction of collagen viscosity 
  4 Phospholipase A Uncoupling of oxidative phosphorylation 
  5 Phospholipase B Hydrolysis of lysophosphatides 
  6 Phosphodiesterase Inhibition of arabinose derivatives, DNA and 
RNA 
  7 5’ nucleotidase Specific hydrolysis of PO4 monoesterase which 
links with 5; position of DNA and RNA 
  8 L amino acid Oxidase Catalysis of amino acid 
  9 Thrombin like enzymes Depression of fibrinogen levels 
  10 Proteolytic enzymes Tissue destruction and bleeding 
  11 Collagenases Collagen digestion 
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PRINCIPAL  FEATURES  OF  ENVENOMATION  BY  DIFFERENT 
FAMILIES   OF   SNAKES 
Elapidea  (krait,  cobra)  principal  manifestation  is  neurotoxicity.  Local  blisters  
and  necrosis  can  occur.  Australian  elapides  cause  bleeding  manifestation.4 
Viperidae  (russell  viper,  saw  scaled  viper)  –  local  swelling,  cellulitis,  regional 
lymphadenitis  and  bleeding  manifestations. 
Hydrophidae (sea  snake)  –  rhabdomyolysis. 
Colubridae - bleeding  manifestation  and  renal  failure.4 
 
CLINICAL  FEATURES: 
                     1. LOCAL  EFFECTS. 
                     2. SYSTEMIC  EFFECTS. 
                     3. COMPLICATIONS. 
 
LOCAL  EFFECTS: 
The  limb  bitten  by  the  snake  shows  increased  vascular  permeability 
leading  to  swelling  and  bruising.  Factors  responsible  include  proteases, 
phospholipases,  hyaluronidase  and  endogenous  autacoids  released  by  the  snake 
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venom  like  histamine  and  kinin.  Venom  of  some  vipers  cause  a  diffuse  increase 
in  vascular  permeability  causing  pulmonary  edema.4.  Local  tissue  necrosis  occurs 
as  a  result  of  direct  action  of  myotoxic  and  cytotoxic  factors,  ischemia  due  to 
thrombosis,  external  compression  by  tight  tourniquets  or  swollen  muscles.4 
Regional  tender  lymphadenitis  is  an  important  clinical  sign,  occurring  early,  and 
is  toxin  mediated.  Local  swelling  is  valuable  sign  of  viper  bite  to  the  extent 
that  its  absence  excludes  viper  bite.  Local  swelling  occurs  rarely  with  the  cobra 
bite,  but  is  not  seen  with  krait  or  sea  snake  bites.9 
 
SYSTEMIC  FEATURES: 
FEAR  AND  EMOTIONAL  REACTIONS: 
         Whether  the  snake  is  poisonous  or  non - poisonous,  fright  is  a  common 
symptom.  Patient  may  appear  semiconscious  with  cold,  clammy  skin,  feeble 
pulse  and  rapid  shallow  breathing.9 
 
BLEEDING  AND  CLOTTING  DISTURBANCES: 
             These  are  commonly  seen  after  viper  bites.  This  is  due  to  procoagulant 
activity  leading  to  consumption  coagulopathy,  anticoagulant  activity  inhibiting 
coagulating  factors  or  due  to  thrombocytopenia.4  In  the  absence  of  trauma  these 
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generally  do  not  cause  spontaneous  bleeding.  If  it  occurs  it  is  usually  attributed 
to  direct  actions  of  hemorrhagic  toxins.4  Commonest  hemorrhagic  manifestation 
seen  in  a  study  done  by  Virmani  and  Dutt  in  Jammu  was  hematuria  while  for 
Reid  it  was  hemoptysis.  Other  common  types  of  bleeding  include  hemetemesis 
and  bleeding  from  gums,  injection  sites,  and  nose.10  Discoid  ecchymoses  have 
been  noted  by  Reid  in  his  studies.  A  few  Australian  land  snakes  can  cause 
hemolysis.4 
 
NEUROLOGICAL  DISTURBANCES: 
Neurotoxic  polypeptides  and  phospholipases  of  snake  venom  cause 
paralysis  by  blocking  transmission  at  neuromuscular  junctions (post  synaptic  for 
cobra,  responds  to  neostigmine,  pre  synaptic  for  krait,  no  response  to  
neostigmine).4 This  is  characteristics  of  kraits,  cobras  and  coral  snakes. 
 
          Early  features  would  be  prominent  forehead  wrinkles,  then  ptosis,  external 
ophthalmoplegia  and  finally  paralysis  of  bulbar  muscles  causing  respiratory 
paralysis.4  Some  patients  bitten  by  elapids  or  vipers  are  in  a  physiologically 
drowsy  state  in  the  absence  of  respiratory  or  circulatory  failure  probably  due  to 
release  and  binding  of  endogenous  opiates.4 
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The  ischemic  lesions  are  more  common  in  snake  bite.  The  probable 
mechanisms  are  vasoconstriction  and  caused  by  venom  or  microthrombi 
formation  as  a  result  of  coagulopathy  and  hypotension.  Viper  bites  have  been 
associated  rarely  with  cerebrovascular  accidents,  most  commonly  due  to 
hemorrhagic  infarct  and  rarely  due  to  ischemic  infarct. 
 
Viper  bite  is  the  most  common  snake  bite  in  the  Indian  subcontinent.  
The  envenomation  by  viper  bite  commonly  presents  with  local  envenomation, 
followed  by  abnormal  coagulation.  The  various  toxins  present  in  the  viper 
venom  have  both  pro- coagulant  and  anticoagulant  effect.  The  toxins  are  with 
well – established  pro-coagulant / platelet  aggregating  properties.11 
 
Following  viper  bite  patients  are  also  at  risk  of  disseminated 
Intravascular  coagulation  and  hypotension.  Disseminated  intravascular  coagulation 
can  cause  of  neurological  disorder  as  a  result  of  large  vessel  occlusion.  The 
toxin  itself  can  cause  vasospasm  which  can  precipitate  a  cerebrovascular 
accident.  All  the  case  reports  of  infarct  following  snake  bite  is  due  to  viper 
bite.  All  these  patients  had  features  of  local  envenomation  and  most  had 
evidence  of  disseminated  intravascular  coagulation.  The  infarct  commonly 
involved  the  anterior  circulation,  with  hemiparesis  being  the  most  common 
presentation.  Study  by  Thomas,  et  al  showed  that  administration  of  the  anti-
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snake  venom  within  six  hours  of  the  viper  bite,  would  prevent  this  
complication. 
 
CARDIAC  MANIFESTATION: 
Electrocardiographic  abnormalities  following  snake  bite  may  be  due  to 
direct  cardiotoxic  action  of  venom,  hypotension  or  electrolyte  disturbances.12  
Present  in  cobra  venom  cardiotoxin  inhibits  direct  and  indirect  stimulation  of 
skeletal  muscle,  decrease  the  acetylcholine  release  at  the  nerve  endings  and 
blocks  axon  conduction .  Some  effects  of  cardiotoxin  resemble  those  of  digitalis 
in  that  it  can  cause  cardiac  arrest  in  systole. 
 
However,  Agarwal  et  al,  in  are  prospective  series  of  55  patients  with 
severe  neurotoxic  snake  envenoming  secondary  to  elapid  snake  bites,  found  no 
clinically  significant  cardiac  involvement.  Tachycardia  and  bradycardia  in  this 
study  may  be  due  to  autonomic  nervous  system  dysfunction  where  tachycardia 
occurred  due  to  sympathetic  stimulation  as  a  result  of  severe  fear  and 
bradycardia  occurred  due  to  parasympathetic  stimulation,  also  as  a  result  of 
severe  fear. 
 
Possible  mechanisms  are  disseminated  intravascular  coagulation  causing  
thrombus   formation  in  coronaries  and  direct  vasculitis  by  snake  venom  causing 
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an  infarction.  Some  snakes  have  sarafotoxins,  which  cause  coronary  
vasoconstriction.  Coronary  spasm  due  to  endothelins  released  by  snake  bite  is 
also  considered  to  be  a  possible  mechanism. 
 
Other  mechanisms  that  suggested  has  causative  for  myocardial  infarction  
(MI) for  viper  bite  are, 
(1).  Hypovolemic  shock  due  to  bleeding 
(2).  Anaphylactic  shock 
(3).  Hypercoagulability  in  consumption  coagulopathy 
(4).  Hyperviscosity  secondary  to  hypovolemia  induced  hemoconcentration 
(5). Direct  cardiotoxic  effect  on  myocardium. 
 
Tony  and  Bhat  et  al,  have  reported  a  case  of  MI  on  day  2 
following  a  snake  bite  and  proposed  vasospasm  caused  by  Viper  snake  venom  
is  a  complex  toxin  with  rich  components  affecting  hemostatic  mechanisms.  Most 
of  the  viper  venom  exhibit  both  anticoagulant  and  coagulant  effects.  Toxic 
vasculitis  caused  by  certain  viper  species  may  result  in  thrombosis.  
 
Common  ECG  findings12  are,  
1) Sinus  bradycardia. 
2) Sinus  tachycardia. 
3) Sinus  arrhythmia. 
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4) Tall  T  waves. 
5) ST  depression  of  1 mm  with  flat  or  inverted  T  waves  in  all  chest  leads 
or  in  anterior  and / or  inferior  leads. 
6) ST  elevation  in  lead  V1  to  V6,  I,  aVL,  Q  wave  in  V1  to  V4  and  ST 
depression  in  II,  III,  aVF. 
7) First  degree  or  second  degree  AV  block. 
 
RHABDOMYOLYSIS: 
Generalized   rhabdomyolysis  with  release  of  myoglobin,  muscle  enzymes 
and  potassium  cause  respiratory  failure,  hyperkalemia  and  occasionally  renal 
failure  (mainly  seen  in  sea  snakes).4 
COMPLICATIONS: 
HYPOTENSION / SHOCK: 
  Pain  shock  due  to  vasovagal  mechanisms. 
  Vasodilating  autacoids  and  oligopeptides  in  viper  venom  inhibit  the 
kininase  enzyme  leading  to  vasodilating  and  shock. 
  Life  threatening  anaphylactic  reactions  in  previously  sensitized  individuals 
within  minutes  of  being  bitten. 
 Hypovolemia. 
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 Pulmonary  intravascular  clotting  due  to  procoagulant  effect  can  cause 
features  of  pulmonary  infarction  and  shock. 
 Direct  myocardial  action  of  toxin  can  contribute  to  hypotension. 
 Pulmonary  edema  due  to  multiple  effects  also  contributes  to  
Shock. 
 
ACUTE KIDNEY INJURY 
PATHOGENESIS: 
The  exact  mechanism  is  not  well  known  due  to  lack  of  animal  model. 
The  factors  contributes  are  direct  cytotoxicity,  bleeding,  intravascular  hemolysis, 
DIC,  MAHA. 
 
Direct  nephrotoxicity: 
 Experimental  studies  shows  excretion  of  venom  from  urine  without 
damage  to  kidneys.  Venom  of  Russell  viper  has  direct  toxic  effect  on  kidneys.14 
In  a  study  administration  of  russell’s  viper  venom  in  rhesus  monkeys  cause 
hemorrhage  in  their  kidneys  and  mild  ATN  within  24  hours.  The  histological 
changes  are  similar  to  the  human  victims. 
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The  strongest  evidence  is  dose  dependent  decrease  in  inulin  clearance  and 
increase  in  excretion  of  sodium.  However  the  study  does  not  includes 
morphological  analysis  of  the  perfused  kidneys.  Willinger  et  al,  studied  the 
combined  functional  and  morphological  kidney  changes  after  russell’s  viper 
venom  administration.  It  induced  changes  in  renal  plasma  flow,  GFR,  filtration 
fraction.  The  excretion  of  sodium  is  increased.  Both  oliguric  and  polyuric  
phases  observed.  The  most  prominent  morphological  changes  observed  in  renal 
cortex.  Extensive  damage  of  the  glomerular  epithelial  cells  observed. 
  
The  venom  leads  to  complete  lysis  of  vascular  smooth  muscle  cells 
leaving  behind  only  the  basement  membrane.  Varying  degrees  of  epithelial 
injuries  occur  in  all  tubular  segments.  In  addition  myoglobinuria,  sepsis,  and 
hypersensitivity  to  venomous  or  anti – venomous  protein  may  also  contribute  to 
renal  failure.  Myoglobinuria  generally  occurs  following  sea  snake  envenomation, 
results  in  necrosis  of  striated  muscles  and  muscular  paralysis. 
 
Intravascular Hemolysis: 
  It  is  the  another  factor  thought  to  have  pathogenic  significance.  It 
is  due  to  the  action  of  phospholipase  A2  which  is  present  in  almost  all  snake 
venoms  and  a  basic  protein  called  “direct  lytic  factor”  found  only  in  elapid 
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venoms.  It  causes  direct  hydrolysis  of  RBC  membrane  phospholipids  or  by 
production  of  hemolytic  lysolecithin.  Anemia,  jaundice,  reticulocytosis,  abnormal 
smear  present  in  50 %  of  patients  with  hemolysis. 
  
Some  studies  have  even  suggested  that  AKI  following  snake  bite  is  an 
example  of  HUS.  However  microangiopathic  hemolysis  as  seen  in  HUS  is 
observed  rarely.  More  than  70 %  patients  with  snake  bite  induced  AKI  shows 
only  ATN  and  do  not  exhibit  glomerular  and  arteriolar  changes  as  seen  in  
HUS. 
 
Glomerular  lesions: 
Whether  or  not  specific  glomerular  lesions  really  occur  is  controversial. 
Sant  and  Purandare  et  al,  reported  a  case  of  “proliferative   glomerulonephritis” 
in  elapidae  bites.  Later  Seedat  et  al,  reported  two  cases  of  crescentic 
glomerulonephritis,  following  puff  adder  bites,  presenting  as  AKI.  These  workers 
ascribed  these  lesion  to  an  allergic  reaction  to  snake  venom.  Sitprija  and 
boonpucknavig  described  two  patients  wuth  crescentic  glomerulonephritis 
following  Russell’s  viper  bite. 
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HEMORRHAGIC  AND  BLOOD  COAGULATION  DISTURBING  ACTION 
OF  SNAKE  VENOM 
PATHOGENESIS  OF  SNAKE  BITE  HEMORRHAGE 
 The  pathogenesis  of  snake  bite  hemorrhage  involves  coagulation 
disturbances  by  venom  anticoagulants,  thrombocytopenia  and  vessel  wall  damage 
caused  by  venom  hemorrhages. 
 
INVIVO  ACTION: 
DISSEMINATED  INTRAVASCULAR  COAGULATION: 
Incoagulability  of  blood  in  animals  dying  from  viper  bite  was  mentioned 
in  eighteenth  century  by  Geoffrey  (1737)  and  Fontana  (1767).  It  is  now 
generally  accepted  that  the  incoagulability  produced  by  venom  is  primarily  due 
to  intravascular  coagulation.  The  mechanism  of  induction  of  intravascular  clot 
varies  with  different  species.  As  already  discussed  above,  it  occurs  mainly  by 
the  direct  conversion  of  fibrinogen  to  fibrin  or  prothrombin  to  thrombin  or 
factor  X  to  XII  activation  by  the  venom.15  Direct  pathological  evidence  for 
intravascular  clotting  in  humans  is   a  demonstration  of  intravascular  clot.  But 
their  absence  on  autopsy  does  not  rule  out  disseminated  intravascular  
coagulation  as  fibrinolysis  can  occur  in  the  postmortem  period.  So  the 
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demonstration  of  a  clot  depends  on  the  time  between  venom  injection,  dose  of 
venom  and  the  time  of  autopsy.14 
 
PRIMARY  FIBRINOLYSIS: 
  In  some  cases  it  was  found  that  when  the  blood  was  left  to  stand  in  a 
test  tube  for  some  time  it  resulted  in  formation  of  a  clot  which  then  lysed  after 
few  minutes.  This  led  on  to  the  study  of  any  other  mechanism  other  than 
disseminated  intravascular  coagulation  being  responsible  for  bleeding  
abnormality.  A  suggested  mechanism  was  the  direct  fibrinogenolytic  activity  of 
venom. 
 
The  importance  of  knowing  whether  primary  fibrinolysis  acts  in  a 
significant  manner  in  snake  bite  coagulation  disturbances  is  of  practical 
therapeutic  importance.  In  case  the  coagulation  disturbance  is  primarily  DIC 
early  stages  would  be  benefitted  by  heparin  therapy  (while  in  case  of  primary 
fibrinolysis  the  condition  will  be  worsened  by  heparin).  The  points  used  for 
differentiation  between  primary  fibrinolysis  and  DIC  are  listed  in  the 
accompanying  table. 
 
37 
 
INACTIVATION  OF  FIBRIN  STABILISING  FACTOR: 
          Though  in vitro  activation  of  fibrin  stabilizing  factor  Echis  Coloratus  has 
been  demonstrated,  in  vivo  inactivation  is  mainly  a  consequence  of  intravascular 
clotting.16 
 
THROMBOCYTOPENIA: 
It  is  known  to  accompany  clinical  and  experimental  defibrination.  Apart 
from  the  fact  that  the  platelets  are  trapped  in  intravascular  clots  venom factors  
(possibly  phosapholipase  A)  contribute  to  platelet  damage.  Clinically  even  in 
those  cases  in  which  thrombocytopenia  is  a  feature,  the  hemorrhage  of  snake 
bite  lacks  the  characteristics  of  thrombocytopenia  in  that  petechiae  are  absent.  It 
is  now  concluded  that  thrombocytopenia  is  not  the  primary  cause  of 
envenomation  hemorrhage,  but  may  be  a  aggravating  factor.16 
 
HEMORRHAGINS: 
           In  coagulability  without  hemorrhage  was  observed  both  clinically  and 
experimentally  in  a  few  cases.14,16  This  led  to  the  assumption  that  hemorrhage  
in snake  also  occurs  due  to  mechanisms  other  than  coagulaton  disturbnce. This  
led to  the  discovery  of  the  vessel  wall  damaging  factor  termed  hemorrhagin  in  
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the snake  venom.17  Earlier  studies  by  Flexner  found  that  these  toxins  cause  rents  
in the  vessel  wall.18  It  was  concluded  red  blood  cells  spurt  through  pores  
developing  in  the  region  of  the  inter  endothelial  substance. 
 
SUPPRESSION  OF  FIBRINOGEN  FORMATION: 
            Snake  venom  is  said  to  inhibit  fibrinogen  formation  in  the  liver  but  this 
is  not  well  established. 
 
COMPARTMENT  SYNDROME: 
            This  is  a  condition  in  which  an  increase  in  tissue  pressure  within  a 
closed  space  impedes,  the  blood  supply  and  functioning  of  the  tissue  within  that 
space.15 
 
          In  viper  bite  swelling  of  muscles  within  tight  fascial  compartment  may 
raise  the  tissue  pressure  to  such  an  extent  that  perfusion  is  impaired  and 
ischemic  damage  is  added  to  the  effects  of  the  venom.13 
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GENERAL  CLINICAL  FEATURES  OF  COMPARTMENT  SYNDROME: 
1.  Pain  disproportionate  to  the  primary  diagnosis 
2.  Pain  worsened  by  the  passive  stretch  of  the  affected  muscles. 
3. Pressure  palpable  over  the  compartment. 
4. Paresis  of  affected  muscles. 
5. Parasthesia  in  the  distribution  of  the  affected  nerves. 
6. Pallor. 
7. Pulseless  in  the  most  severe  cases. 
 
GUIDELINES  FOR  THE  INTREPRETATION  OF  TISSUE  PRESSURE 
MEASUREMENTS  IN  NORMOTENSIVE  AND  HYPOTENSIVE  PATIENTS 
Tissue  pressures  less  than  20 mm Hg  are  essentially  normal.  Pressure 
between  20  and  30  mm Hg  require  careful  follow  up  and  serial  pressure 
measurements.  Compartment  pressures  greater  than  30 mm Hg  suggest  the  need 
for  immediate  fasciotomy.  Hypotensive  patients  may  develop  compartment 
syndrome  at  lower  tissue  pressures  and  fasciotomy  should  be  considered  when 
the  compartment  pressure  is  within  10  to  30 mm Hg  of  the  diastolic  blood 
pressure  (Whiteside  and  associates  1875)  Medical  therapy,  including  vasodilating 
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drugs  and  sympathetic  blocking  agents,  is  not  effective  in  the  treatment  of  acute 
compartment  syndrome  (Christenson. JT,  wulff K 1985,  Hutchinson,  MR Ireland 
ML, 1994). 
 
MANAGEMENT 
General Measures 
DO  IT  R.I.G.H.T  protocol 
• Reassure  the  victim4 
• Immobilize  the  bitten  limb  using  a  splint  or  sling  as  muscular 
• Get  to  Hospital  immediately 
• Tell  the  doctor  about  symptoms 
• Cauterization,  incision  and  drainage,  amputation,  usage  of  venom  pumps, 
instillation  of  chemical  compounds  and  electric  shock  locally  are  all  to  be 
avoided  as  these  will  cause  uncontrolled  bleeding  from  the  site  and 
damage  of  nerves  and  vessels,  leading  to  necrosis.4 
• Use  of  tourniquets  are  controversial,  dangers  of  their  application  include 
ischemia  and  gangrene,  damage  to  peripheral  nerves  and  increased  local 
effect  of  venom.  But  in  case  of  cobra  or  sea  snake  if  medical  therapy  is 
likely  to  be  delayed  a  firm  crepe  bandage  can  be  applied 
• Inj. Tetanus  toxoid  should  be  given. 
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SPECIFIC  THERAPY 
Antisnake  Venom  Therapy 
INDICATIONS: 
Distinction  of  poisonous  from  non-poisonous  snake  is  often  difficult  and 
is  not  usually  important  for  the  clinician.  It  is  known  that  about  15  drops  of 
viper  venom  can  be  fatal  to  an  adult  and  3  drops  of  cobra  venom  could  be 
lethal  and  one  drop  of  sea  snake  venom  could  kill  5  men.  Fortunately,  human 
bite  is  defensive  reaction  which  rarely  results  in  much  of  venom  being  
injection.  Following  poisonous  snake  bite  more  than  half  of  victims  will  have 
minimal  or  no  poisoning  and  only  a  quarter  will  develop  systemic  poisoning. 
Hence  poisonous  snake  bite  is  not  synonymous  with  snake  bite  poisoning.  So 
even  though  the  snake  is  identified  as  poisonous  or  there  are  bite  marks, 
treatment  should  be  given  only  if  there  are  signs  of  envenomation.  Anti 
snakevenom  itself  can  be  fatal  and  it  is  costly  drug  with  limited  supply.9 
 
CLINICAL  INDICATIONS: 
• Hemostatic  abnormalities 
• Neurotoxicity 
• Generalized  rhabdomyolysis 
• Definite  of  local  envenomation 
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CONTRAINDICATIONS: 
 There  is  no  definite  contraindication  as  Antisnake  venomes  the  only 
specific  therapy  for  snake  bite.  Atopic  patients  and  those  who  had  reaction  to 
equine  antiserum  on  previous  occasions  have  an  increased  risk  of  developing 
server  antivenom  reactions.  It  can  be  ameliorated  by  pre-treatment  with 
adrenaline,  anti-histamine  and  corticosteroids.4 
 
TYPES  OF  ANTISNAKE  VENOM 
 Mono-specific  forms  are  more  effective  and  less  likely  to  cause  reactions 
than  polyspecific  antivenom.  In  most  developing  countries  only  single 
polyspecific  antivenom  is  available.20  In  India  ASV  is  produced  by  Haffkine 
Institute,  Bombay  and  Central  Research  Institute,  Kasauli.  It  is  produced  by 
hyper  immunizing  horses  against  the  common  four  poisonous  snakes  (Cobra, 
Krait,  Russell’s  and  Saw  scaled  viper).1 
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MANUFACTURING  AREAS  OF  ASV 
 
        PUBLIC  SECTOR 
 
PRIVATE  SECTOR 
 
Central  Research  Institute (CRI),  
Shimla  hills,  Kasauli  HP 
 
VINS  bioproducts  Ltd,  Hyderabad 
 
King’s  institute  of  preventive 
medicine,  Chennai 
 
Biological  E  Ltd,  Hyderabad 
 
Haffkine  biopharmaceutical  company 
Ltd.  Mumbai 
 
Bharat  serum  and  vaccine  limited 
 
Bengal  chemical  and  pharmaceutical 
limited,  Kolkata 
 
Serum  institute  of  India  limited,  Pune 
 
DOSE OF ANTI-VENOM 
  The  dose  schedule  for  the  polyvalent  and  monovalent  antisnake 
venom  varies.  We  know  the  lethal  dose  of  Cobra  is  0.12g,  krait  0.06g,  Russell 
Viper  –  0.15 g,  Echiscarinatus – 0.08 g.6  Polyvalent  anti-snake  venom  1  ml 
neutralizes  0.6 mg  of  cobra  venom,  0.45 mg  of  Krait,  0.6 mg  Russell  viper  and 
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0.45 mg  of  Saw  Scaled  viper  venom.  Based  on  this  if  the  poisonous  snake  is 
known,  dose  of  antisnake  venom  can  be  estimated  theoretically.  But  practically 
it  is  not  applicable  as  amount  of  venom  injected  in  each  patient  varies  and 
invitro  studies  do  not  correlate  with  in  vivo  results.  Bases  on  the  results  of  a 
number  of  studies  the  dose  of  antisnake  venom  conventionally  recommended  as 
initial  dose  if  snake  is  know  is common krait - 100 ml  of haffkine polyspecific  
antivenom,  Russel  viper  - 100ml,  Indian  Cobra – 100 ml  and  Echis Carinatus  – 
100 ml.  If  the  snake  is  not  known  the  recommended  amount  of  anti  snake 
venom  given  based  on  clinical  signs  is  50 ml,  100 ml  and  150 ml  for  grades  I 
and  III.  For  patients,  presenting  with  neurotoxic  features  initial  dose  of  ASV 
given  is 100 ml.21 
  
The  apparent  serum  half-life  of  antisnake  venom  in  envenomated  patients 
ranges  from  26  to  95  hours  depending  on  how  they  are  prepared.  Though  it 
clears  the  venom  from  the  circulation  immediately,  the  clinical  effect  on  clotting 
restoration  occurs  usually  after  four  hours.  Thus  if  dose  has  been  adequate 
clotting  time  should  be  normal  by  6  hours.4,22  Neurotoxic  sings  improve  within  
30 minutes  but  may  take  several  hours.  A  second  dose  is  given  if  neurological 
features  persist  for  more  than  30  minutes.  Dose  of  ASV  is  the  same  for  adults 
and  children.4 
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 There  is  controversy  about  how  long  after  envenomation  Anti-venom 
therapy  is  still  effective.  Carrison  et  al,  claim  that  it  is  most  useful  if  given 
within  4 hours,  less  delayed  for  8 hours,  and  doubtful  if  after  24  hrs.23  
However, Dwivedi  et  al,  have  reported  therapy  with  Anti-snake  venom  to  be  
beneficial even  after  8  days  and  state  that  there  is  no  fixed  time  limit.24 
 
MODE OF ADMINISTRATION 
Local  Injection: 
 If  it  is  possible  to  inject  anti-venom  locally  at  the  site  of  bite  with  in  a 
few  minutes,  necrosis  might  well  be  prevented.  But  in  practice  this  is  virtually 
never  possible  and  therefore  is  not  advocated.  
 
Intravenous  Injection 
It  is  the  most  effective  route.  An  infusion  of  anti-snake  venom  mixed 
with  isotonic  fluid  is  given  in  1:3  dilutions.  It  is  given  over  30 - 60  minutes, 
initially  starting  with  10 - 15  drops / min  and  then  increasing  the  dose.4  ASV  
can also  be  given  direct  intravenous  push.  Its  been  found  there  is  no  difference  
in reaction  between  the  two  methods.25 
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ANTIVENOM  REACTIONS  AND  TEST DOSE: 
Antivenom  therapy  is  complicated  by  three  types  of  reactions. 
1.  Anaphylactic  (early) 
2.  Pyrogenic. 
3.  Late  serum  sickness  type  of  reaction. 
 
EARLY  ANAPHYLACTIC  REACTIONS: 
               It  was  initially  thought  to  be  Ig E  mediated.  But  complement  activation 
by  IgG  aggregates  or  residual  Fc  fragments  or   direct  stimulation  of  mast  cells 
or  basophils  by  antivenom  protein  are  the  more  likely  mechanisms.  However,  in 
most  there  is  no  prior  exposure  the  serum.  Skin  test  dose  reactions  do  not 
correlate  with  the  incidence  of  reactions  occurred  during  ASV  administration.4,21 
Complement  activation  is  also  implicated,  but  not  proved.21  Clinical  features 
include  itching,  utricaria,  fever,  tachycardia, palpitations,  nausea,  vomiting. 
Minority  may  develop  severe  hypotension,  bronchospasm  and  angioedema.  Early 
reactions  are  managed  by  0.5  ml  of  0.1 %  adrenaline  subcutaneous  and 
chlorpheneramine  maleate  10 mg  IV.4 
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PYROGENIC  (ENDOTOXIC)  REACTIONS:  
It  results  from  contamination  of  antisnake  venom  endotoxin  like 
compounds.  Develops  after  1 - 2  hours  after  treatment.  Symptoms  include  fever, 
vasodilatation  and  fall  in  Blood  Pressure.  High  fever  occurs  which  is  treated 
with  paracetamol.4 
 
LATE (SERUM SICKNESS TYPE) REACTION: 
               It  develops  5 - 24  days  later,  characterized  by  fever,  itching,  urticaria, 
arthralgia  and  lymphadenopathy,  mononeuritis  multiplex,  proteinuria  with  immune 
complex  nephritis  and  rarely  encephalopathy.  It   is  treated  with  chlorpheniramine 
2 mg  four  times  daily  or  prednisolone  5 mg  four  times  daily  for  5  days.4 
 
The  rule  of  the  intradermal  test  with  0.2 ml  of  ASV,  though  widely 
followed  is  controversial.  According  to  some  authors,  this  test  only  delays  the 
onset  of  definite  therapy  and  has  no  role  in  the  prediction  of  early  or  late  anti 
snake  venom  reactions.4,25 
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OTHER  SUPPORTIVE  MEASURES: 
Neurotoxic  Effects - Artificial  Ventilation: 
            Intravenous  neostigmine  0.5 mg  given  at  half  hourly  interval  for  five 
injections.  This  is  followed  by  same  dose  at  increasing  intervals  of  2  to  12 
hours,  according  to  neurological  recovery.  Each  dose  of  neostigmine  is  preceded 
by  0.5 mg  atropine.6 
 
SHOCK  –  plasma  expanders,  dopamine  infusion,  steroids  are  used. 
RENAL  FAILURE: 
 During  initial  oliguric  phase  (less  than  400 ml / 24  hours)  dopamine 
infusion  at  the  rate  of  2.5 mg / kg / min  or  diuretics  are  used.  In  established 
renal  failure,  dialysis  is  indicated.4 
 
LOCAL  INFECTION: 
               Intra  compartmental  syndrome -  broad  spectrum  antibiotics  are  used.  
Blisters  are best  left  undisturbed.  Slough  should  be  excised.  Swelling  of  muscles  
within  tight  fascial  compartment  may  raise  the  pressure  leading  to  impaired  
perfusion and  ischemia.  In  these  circumstances  fasciotomy  is  indicated.  It  should  
be  done only  after  blood  coagulopathy  has  been  treated. 
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Steroids  are  advocated  in  both  patients  presenting  with  bleeding  
tendencies  and  with  neurological  manifestations  (hydrocortisone  50  to  100  mg  
i.v  8th  hourly).  However,  its  use  remains  controversial.24 
 
HEPARIN: 
           Some  studies  showed  that  if  heparin  10, 000  units  is  given  intravenous 
stat  followed  by  5000  units  8th   hourly  i.v  and  continued  for  4  hours  is  useful 
in  the  prevention  of  DVT.  Yet  other  have  shown  that  it  is  ineffective  and 
worsens  bleeding.18 
FIBRINOGENS  INFUSIONS  are  not  helpful14 
 
BLOOD  TRANSFUSION: 
It   helps  in  viper  bite  shock  secondary  to  bleeding  and  also  in  the 
management   if  specific  antivenom   is  not  available. 
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PREVENTION  OF  SNAKEBITE 
 
Snakes  have  adapted  to  a  wide  range  of  habitats  and  prey  species.  All 
snakes  are  predatory  carnivores,  none  are  vegetarians  although  some  eat  eggs. 
Since  snakes  are  preyed  upon  by  other  animals,  they  tend  to  be  secretive  and 
have  evolved  many  survival  strategies.  By  understanding  something  about  
snakes  habits,  simple  precautions  can  be  adopted  to  reduce  the  chance  of 
encounters  and  subsequent  bites.  Some  truths  apply  to  all  snakes,  they  prefer 
not  to  confront  large  animals (such  as  humans).  Thus,  it  is  best  so  give  them 
the  chance  or  time  to  slither  away.  Some  species  are  mainly  nocturnal  hunters, 
and  other  species  are  mainly  diurnal  hunters.  Many  snakes  are  non-venomous, 
while  others  are  only  mildly  venomous  and  not  particularly  dangerous  to 
humans.  However,  a  few  are  highly  venomous  and  their  bites  are  potentially 
lethal.  Snakes  are  necessary  for  maintaining  a  healthy  balance  in  nature,  they 
should  not  be  killed  unnecessarily.  It  is  important  that  everyone  learn  which 
dangerous  snakes  occur  in  the  local  community  or  area.  
 
• In  the  house,  where  snakes  may  enter  in  search  of  food  or  to 
find  a  hiding  place  for  a  short  time.  
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• Do  not  keep  livestock,  especially  chickens,  in  the  house,  as  some 
snakes  will  come  to  hunt  them.  
 
• Store  food  in  rat-proof  containers.  
 
• Raise  beds  above  floor  level  and  use  an  insecticide  impregnated 
mosquito  net,  completely  tucked  in  under  the  sleeping  mat.  This 
guards  against  centipedes,  scorpions,  and  snakes  as  well  as  malaria 
mosquitoes  and  many  ectoparasites (fleas,  lice,  bed  bugs  etc) 
(Chappuis  et  al,  2007).  
 
• In   the  farmyard,  compound,  or   garden  try  not  to  provide  hiding 
places  for  snakes.  
 
• Use  a  light  and  wear  proper  shoes  when  walking  outside  at  night.  
 
• Clear  heaps  of  rubbish,  building  materials  and  other  refuse  from  near 
the  house.  
 
• Do  not  have  tree  branches  touching  the  house.  
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• Keep  grass  short  or  ground  clear  around  your  house  and  clear 
underneath  low  bushes  so  that  snakes  cannot  hide  close  to  the 
house.  
 
• Keep  your  granary  away  from  the  house  (it  may  attract  animals 
that  snakes  will  hunt).  Water  sources,  reservoirs  and  ponds  may 
also  attract  animals  of  prey.   
 
• Listen  to  wild  and  domestic  animals,  they  often  warn  of  a  snake 
nearby.  
 
• In  the  bush  or  countryside,  firewood  collection  at  night  is  a  real 
danger.  
 
• Watch  where  you  walk.  Step  on  to  rocks  or  logs  rather  than 
straight  over  them  as  snakes  may  be  sunning  themselves  on  the 
other  side.  
 
• Do  not  put  hands  into  holes,  nests  or  any  hiding  places  where  
snakes  might  be  resting.  
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• Wild  animals,  especially  birds,  may  warn  of  snakes  nearby.  
 
• Be  careful  when  handling  dead  or  apparently  dead  snakes  even  an 
accidental  scratch  from  the  fang  of  a  snake’s  severed  head  may 
inject  venom.  Some  species  such  as  the  rinkhal  (Hemachatus 
haemachatus)  may  sham  death  as  a  defensive  tactic.  
 
• Many  snakebites  occur  during  ploughing,  planting  and  harvesting 
and  in  the  rainy  season.  Rain  may  wash  snakes  and  debris  to  the 
edges  of  roads,  and  flush  some  species  such  as  burrowing  asps 
(Atractaspis)  out  of  their  burrows  Pedestrians  should  be  careful 
when  walking  on  roads  after  heavy  rain  especially  after  dark.  
 
• Drivers  or  cyclists  should  never  intentionally  run  snakes  over  on 
the  road.  The  snake  may  not  be  instantly  killed  and   may  lie 
injured  and  pose  a  risk  to  pedestrians  and  other  cyclists.  The 
snake  may  also  be  injured  and  trapped  under  the  vehicle,  from 
where  it  will  crawl  out  once  the  vehicle  has  stopped  or  has  been 
parked  in  a  compound  or  garage.40  
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Essential  Medicines  and  Supplies  for  Managing  Snakebite  at 
a  District  Hospital   
 
In  order  for  health  workers  to  deal  effectively  with  cases  of  snakebite,  it  is 
important  that  certain  essential  supplies  are  available  in  their  health  facilities  and 
that  they  are  trained  in  the  best  methods  for  using  them.  Below  is  a  list  of 
recommended  essential  supplies  for  the  management  of  snakebite.  It  can  be 
modified  to  suit  the  needs  of  local  health  workers,  depending  on  their  specific 
training  and  aptitude  in  dealing  with  snakebite  victims.  
 
1. Antivenom  (with  sterile  water  for  reconstituting  lyophilized  antivenom)  
2. Tetanus  toxoid  
3. Epinephrine  (adrenaline)  injection 0.1 %  (1:1,000)  (1 mg/ml)  
4. Parenteral  antihistamine  and  hydrocortisone  
5. Pain  killers  e.g.  paracetamol  and  codeine  
 NOT  aspirin  or  nonsteroidal  anti-inflammatory  agents  
6. Antipyretics  (paracetamol  tablets,  syrups  and  suppositories)  
7. Local  anaesthetic  agents (1 - 2 %  lidocaine)  
8. Intravenous  (IV)  fluids  e.g.  normal  saline  (0.9 %  NaCl)  
9. Vasopressor  drug  e.g.  phenylephrine,  adrenaline  and  nonadrenaline   
10. Atropine  and  edrophonium  or  neostigmine  (Prostigmin)  for  “Tension  Test”  
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11. Fresh  frozen  plasma  or  cryoprecipitates  
12. Blood  platelets  
13. Oxygen  cylinders  with  spanners,  gauges,  necessary  connectors  
14. Antibiotics  (chloramphenicol,  benzylpenicillin,  flucloxacillin,  metronidazole, 
gentamicin,  amoxicillin-clavulanic  acid)  
15. Laryngoscope  (adult  and  paediatric  sizes)  with  spare  batteries  and  bulbs  
16. Cuffed  endotracheal  tubes  (various  sizes)  
17. Ambu  bag  with  connectors  to  endotracheal  tube  and  face  mask  that  fit  
18. Face   masks  and  oral  airways  
19. Suction  apparatus  and  catheters  
20. Urine  dip  sticks  
21. New,  clean,  dry  glass  vessels  for  20WBCT  
22. Syringes,  needles,  intravenous  cannula  
23. IV  administration  set  
24. Sticking  plaster  
25. Scissors  
26. Splints  
27. Urethral  catheters  
28. Bathroom  type  weighing  scales  
29. Stretchy,  elasticated  crepe  bandage  and  splint.40 
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Immediate  Measures  after  snake  bite: 
 
Capture  snake 
 
NO 
 
Incise  fang  marks 
 
NO 
 
Oral  suction 
 
NO 
 
Ice 
 
NO 
 
Tourniquet 
 
NO 
 
Constriction  band 
 
NO 
 
Splint  and  sling 
 
NO 
 
Electric  shock  to  denature  venom 
 
NO 
 
Rapid  transport 
 
YES 
 
Start  I.V  line 
 
YES 
 
Emergency  medical  services 
 
YES 
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MATERIALS  AND  METHODS 
STUDY  POPULATION 
 Hundred  patients  with  the  history  of  snake  bite  admitted  in  Thanjavur 
Medical  College  Hospital  during  the  period  Jan  2016  to  May  2016  was  taken 
up  for  this  study. 
SELECTION  CRITERIA 
 Patients  presenting  with  the  history  of  snakebite  with  or  without  evidence 
were  taken  up  for  the  study.  Patient  with  the  history  and  definitive  evidence  of 
snakebite  in  the  form  of  local  cellulitis,  regional  lymph  adenitis,  and / or 
prolonged  clotting  time,  taken  as  suggestive  of  bite  were  considered  under 
venomous  group. 
 Patient  with  neurotoxic  manifestation  like  Ptosis,  dysphagia  external 
ophthalmoplegia  were  also  included  in  the  study  under  venomous  group.  Patient 
with  the  history  of  unknown  bite,  with  or  without  local  swelling  with  normal 
clotting  time  were  categorized  under  non  venomous  group  and  included  in  the 
study. 
 Patients  having  local  swelling  due  to  tourniquet  application  and  local 
native  treatment  were  also  considered  for  the  study. 
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Study  population  is  divided  according  to  severity  into  four  grades 
 
                    
                 GRADE III 
                      
              GRADE IV 
 
Prolonged  clotting  time 
With  or  without  local  features 
 
 
Local  features 
Prolonged  clotting  time 
With  systemic  bleeding 
 
 
              
                        GRADE I 
               
                   GRADE II 
 
History  of  snake  bite 
With  or  without  cellulitis 
Normal  clotting  time 
 
Local  cellulitis 
Regional  lymphadenitis 
Normal  clotting  time 
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EPIDEMIOLOGICAL  DATA 
1. The  age  and  sex  incidence  of  snake  bite 
2. Age  group  affected 
3. Occupational  incidence 
4. Outdoor  and  indoor  incidence 
5. Urban  and  rural  incidence 
6. Seasonal  incidence 
7. Diurnal  incidence 
8. Body  site  of  bite 
9. Type  of  snake  bite 
 
CLINICAL  MANAGEMENT  DATA 
1. Average  number  of  anti  snake  venom  vial  used 
2. Complication  encountered  including  that  of  antivenom  administration 
3. Number  of  venomous  bite  cases  gone  in  for  renal  failure 
4. Incidence  of  venomous  bite  cases  gone  in  for  neuroparalysis 
5. Number  of  venomous  bite  cases  gone  in  for  coagulation  failure 
6. Incidence  of  venomous  bite  case  of  gone  in  for  compartment  syndrome 
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The  following  basic  investigations  for  all  the  cases  were  done. 
Total  Leukocyte  count  –  using  Turke’s  fluid 
Normal  value :  4,000  to  11,000  cells / cu.mm  of  blood 
 
Differential  counts –  using  Leishman’s  stain 
Normal  value :   
                            Polymorpho  nuclear  neutrophils  –  62.0% 
        Polymorpho  nuclear  eosinophils  –  2.3% 
                            Polymorpho  nuclear  basophils     –  0.4% 
        Monocytes                                      -  5.3% 
        Lymphocytes                                  -  30.0% 
Red  blood  cell  count  –  using  Hayem’s  diluting  fluid 
Normal  value :   
Men : 5.2 millions / cu. mm  of  blood 
Women :  4.7  millions / cu. mm  of  blood 
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PLATELET  COUNT 
 The  stain  used  was  brilliant  cresyl  blue  prepared  by  mixing  0.3  gms 
percentage  of  brilliant  cresyl  blue  crystals  with  one  drop  of  formalin  and  100ml  
of  distilled  water.  Using  a  RBC  pipette  blood  was  taken  upto  the  0.5  reading 
and  brilliant  cresyl  blue  fluid (1  in  200  dilution)  till  the  101  mark.  It  was  left  
2  minutes  and  then  charged  with  a  cover  slip  into  a  Neubar  chamber.  Platelets 
were  seen  a  bluish  pink  spots.  Normal  range  1.5  –  3  lakhs / cu. mm. 
 
URINE: 
Albumin  -  Heat  and  acetic  acid  test 
Sugar –  Benedicts  test 
Deposits – sediment  of  the  centrifuged  urine  seen  through  microscope 
Urine  albumin :  Normal  value –  Negative  
Urine  myoglobin: 
Method: 
 Qualitative  test  of  myoglobin  by  blond  Herim  1958.  T0  5ml  of  urine  
add  2.8  gm  of  Ammonium  sulphate,  dissolved  by  mixing.  The  urine  is  80 % 
saturated  with  Ammonium  Sulphate.  This  is  optimal  for  the  precipitation  of  the 
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Hemoglobin.  Then  filter  and  centrifuge.  If  supernatant  shows  normal  color  the 
precipitated  protein  is  Hemoglobin.  If  the  supernatant  protein  is  colored  that  is 
due  to  myoglobin. 
Urine  Sugar : Normal  value  –  Negative 
Urine  deposits: 
           Red  cells  and  red  cell  casts: 
 Normal  value  of  RBCs 
 1  to  2  / LPF (Low  Power  Field) 
 0  to  1 / hpf (high  power  field) 
Red  cells  casts – Nil  (zero) / LPF 
White  cells  and  white  cell  casts 
Normal values: 
 RBCs  –  0  to  5 / HPF 
 WBC  Casts :  none (zero) / LPF 
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Epithelial  cells  and  epithelial  casts 
Normal  values :  Occasional  Renal  epithelial  cell  may  be  found. 
HYALINE  CASTS: 
Normal  value : Occasionally  hyaline  cast / LPF  may  be  found. 
GRANULAR  CAST: 
Normal  value : Occasionally  granular  cast  may  be  seen. 
WAXY  CASTS: 
Never  seen  in  healthy  subjects. 
OVAL  FAT  BODIES  AND  FATTY  CASTS: 
Never  seen  in  healthy  individuals. 
Blood  group - by  slide  agglutination  method. 
 
BLEEDING  TIME: 
Bleeding  time  was  estimated  by  dukes  method.  Here,  a  needle  prick  was 
given  on  the  tip  of  the  finger,  about  one  centimeter  deep  and  the  blood  
bleeded  off.  The  time  taken  for  bleeding  to  stop  was  noted. 
Normal  range -  3  to  5  minutes. 
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CLOTTING  TIME: 
      Though  there  are  various  methods  of  assessing  the  clotting  time (the 
normal  by  lee  and  white – 6  to  9  minutes,  Dale  and  Laid -  3  to  5  minutes),  the 
method  selected  for  our  study  was  that  of  Ulnas,  for  practical  reasons.  By  this 
method  2ml  of  blood  was  kept  undisturbed  in  a  pyrexex  test  tube  (10 cm  tall 
and  inside  diameter  1  cm).  After  5  minutes  test  tube  was  gently  tilted  to  45 
degree  and  tested   for  clotting  procedure  was  repeated  every  minute  until  the 
blood  clotted.  The  normal  clotting  time  by  this  method  was  in  the  range  of  9 
to  15  minutes.  The  sample  was  left  behind  to  assess  the  clots  quality. 
 
PROTHROMBIN  TIME: 
   Although  originally  thought  that  measure  prothrombin  time  the  test  is 
now  known  to  depend  also  on  reactions  with  factors  V,  VII  and  X  and 
fibrinogen  concentration.  Thus  the  name  [prothrombin  time  is  not  accurate.  This 
tests  the  effectiveness  of  extrinsic  pathway.  Test  was  done  with  both  patient  
and  control  plasma,  0.1 ml  of  plasma  in  a  glass  tube  was  placed  in  a  water 
bath  at  37  degree  for  3  to  5  minutes  and  0.2 ml  of  liquiplastin  reagent  was 
added.  Time  taken  for  the  sample  to  clot  was  noted.  Normal  values  depend  on 
the  thromboplastin  used.  The  normal  is  10 - 14  seconds.  Test  is  abnormal  if 
prolonged  by  more  than  2  seconds  over  the  control  value.23 
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Serum  electrolytes  – by  flame  photometry. 
Normal  values: 
Serum  sodium – 136  to  145  meq / L 
Serum  potassium - 3.5  to  5  meq / L 
Serum  cholesterol -  Estimated  by  ZAK  method.  Normal  150  to  250  mgs. 
Plasma  fibrinogen  levels: 
Reagents  used:  
1. Ammonium  sulphate  –  13.3  of  ammonium  and  1 gm  of  sodium  chloride  in 
100 ml  of  distilled  water.  pH  is  adjusted  by  adding  10 N  NAOH. 
2. Normal  saline :  9  gms  of  sodium  chloride  in  1  liter  of  water. 
             TEST                                                        BLANK 
0.5  ml  plasma  and  0.5 ml  normal to           1 ml  of  normal  saline added  9ml  of                            
saline    added  to  9ml  of                                    Ammonium  sulphate 
 ammonium  sulphate  solution          
Shake  and  read  after  5  minutes 
With  420  filter. 
Result =  test  –  blank = Blood. Fibrinogen  in  mgm %  (Normal  200 – 400 mgm %) 
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THE  FOLLOWING  SPECIAL  INVESTIGATIONS  WERE  DONE: 
DUPLEX -  B  mode  Doppler  study  was  done. 
DUPLEX  DOPPLER: 
These  machines  combine   real  time  imaging  with  pulsed  Doppler.  This 
allows  the  operator  to  identify  a  specific  segment  in  a  particular  vessel  and  to 
place  a  gate  or  sample  volume,  at  a  specific  location  so  that  the  source  of 
Doppler  signal  is  none.  The  time  taken  by  the  pulses  of  ultrasound  to  travel  to 
and  from  the  blood  vessels  means  that,  for  Deeper  vessels  the  pulse  repetition 
frequency  is  limited  as  the  system  wait  for  a  pulse  to  return  before  transmitting 
the  next  pulse.  This  means  that  the  magnitude  of  Doppler  shifts  which  can  be 
measured  is  limited  and  detection  of  higher  shifts  in  deeper  level  may  not  be 
possible  in  certain  circumstances.  The  Doppler  information  is  transmitted  as  an 
audio  signal  and  as  a  spectral  display  scrolling  across  the  scene. 
 
Vessels  have  different  wave  forms  or  Doppler  signals  which  depends  on 
the  size  of  the  blood  vessel  and  type  of  the  capillary  bed  it  is  supplying.  The 
wave  form  characteristics  can  change  significantly  in  response  to  physiological 
stimuli  as  shown  by  increased  diastolic  flow  which  is  seen  in  the  femoral 
arteries  on  exercising  the  leg  muscles. 
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Compartment  pressure  study  was  done  for  43  patients  with  cellulitis  by 
“syringe  manometer”  technique.  Tissue  compartment  pressure  can  be  measured 
with  minimal  equipment  available  using  the  “syringe  manometer”  technique          
(Whitesides  TE,  Haney,  TC,  Morimoto,  K  et  al, 1975).  
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ANALYSIS  OF  RESULTS 
GENERAL  FEATURES: 
   A  total  of  100  patients  were  admitted  in  Thanjavur  Medical  College 
Hospital  general  medical  wards  from  January  to  May  2016  with  either  history  
or  features  suggestive  of  snake  bite.  Of  the  100  patients  with  snake  bite  43  had 
features  suggestive  of  coagulation  abnormality.  Six  patients  presented  primarily 
with  neurotoxic  manifestation.  Two  patients  has  hemostatic  and  neurotoxic  
abnormality.  Rest  of  the  49  patients  had  no  features  suggestive  of  snake  bite   
51 %  were  poisonous  and  49 %  were  nonpoisonous  which  is  depicted  in figure 
1.  Of  the  poisonous  bite  84.32 %  had  primary  coagulation  abnormality  and  
11.76 %  had  neurotoxic  manifestation  and  3.92 %  both. 
Figure 1 : Distribution  of  Snake  Bite 
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 Out  of  the  51  patients  admitted  with  features  of  envenomation  were  
selected at  random  for  the  study.  The  average  age  of  the  patients  in  our  study  
was  28 years  ranging  from  8  years  to  70  years.  Majority  of   snake  bite  occurs  in  
20  to  45  years  which  is  depicted  in  figure 2. 
 
Figure 2: Age  Distribution  of  Snake  bite 
 
In  this  study  among  the  poisonous  snake  bite  males  74.51 %  were  bitten  
more  than  females  25.49 %   which  is  depicted  in  table 1.   
Table 1:  Gender  distribution 
Gender Total  Percentage 
Males 38 74.51 
Females 13 25.49 
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The  study  population  was  grouped  into  4  categories  grades  I,  II,  III  and  IV 
according  to  clinical  features  and  clotting  time.  Of  which  grade  IV  category  not  
present  in  this  study.  12  patients  belonged  to  grade  I,  27  to  grade  II  and  another 
12  to  grade  III  (23.53 %, 52.94 %  and 23.53 %) respectively.  These  patients  were 
subjected  to  various  coagulation  parameter  assessment  tests.  
 
Table 2: Distribution  of  Species of  Snake bite 
Type of Snake Total Percentage 
Russel Viper 3 5.88 
Saw scaled Viper 9 17.65 
Krait 2 3.92 
Unidentified 37 72.55 
 
In  this  study  majority  of  snake  bite  was   unidentified (72.55%)  species. After  
that  Saw  Scaled  Viper (17.65%),  Russel  Viper (5.88%),  Krait (3.92)  which  was  
illustrated  in  Table 2 .  
 
Majority  of  the  patients  had  bite  on  the  lower  limb 66.66 %. The  incidence 
of  bite  in  the  upper  limb  was  33.34 %  which  was  depicted  in  figure 3. The 
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average  duration  of  hospital  stay  of  the  snake  bitten  individuals  with  clotting 
abnormality  was  6  days,  ranging  from  2  to  28  days. 
 
Figure 3 : Distribution of  Site of snake bite 
 
 
ASSESSMENT  OF  CHANGES  IN  COAGULATION  PROFILE 
Blood  is  taken  at  the  time  of  admission  before  therapy  was  started  in  those 
having  definite  envenomation  excluding  neurotoxic  manifestations. 
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CLOTTING  TIME 
          Of  the  51  patients,  72 %  have  prolonged  clotting  time  at  the  time  of 
admission.  In  3  cases  (6.25%)  clotting  time  was  normal  during  admission  but  
turned abnormal  in  a  period  of  4-12  hours.  In  total  79 %  have  prolonged  clotting  
time. 
 
BLEEDING  TIME 
In  all  cases  it  was  found  to  be  normal  even  in  cases  who  had  bleeding 
manifestations.  The  average  bleeding  time  was  found  to  be  2 - 6  minutes. 
 
PLATELET  COUNT 
Platelet  count  was  found  to  be  reduced  in  all  cases  belonging  to  both 
grades  II  and  III.  The  average  platelet  count  was  97,486 cells / cu.mm.  Thus  a 
100%  reduction  was  noted.  The  average  count  in  grade  I  was  2.3  lakhs. 
 
PROTHROMBIN  TIME 
This  test  is  done  primarily  to  evaluate  any  abnormality  in  extrinsic  
pathway.  It  was  done  in  11  out  of  12  cases  belonging  to  grade  I  (that  is  local 
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features  with  normal  clotting  time).  The  test  was  found  to  be  normal  in  all.  But 
one  out  of  12  cases  who  belonged  to  grade  I  with  prolonged  prothrombin  time 
went   to  develop  abnormal  coagulation  profile  over  a  period  of  six  hours.. 
 
In  grade  II,  20  out  of  27  cases  were  evaluated  for  prothrombin  time  and  in 
grade  III,  9  out  of  12  cases  were  tested.  All  these  patients  showed  prolongation  
of  prothrombin  time  denoting  a  100 %  positivity. 
 
Table 3 : Laboratory Profile  of  Snake  Bite 
Laboratory  Profile Mean Standard  Deviation 
Bleeding   Time  3.74 1.56 
Clotting  Time  9.54 1.85 
PT  –  INR 20.8 1.05 
Urea 42 1.26 
Creatinine 2.1 1.36 
 
CORRELATION  OF  COAGULATION  ABNORMALITY  WITH  THE  TYPE 
OF  SNAKE 
In  12  out  of  51  patients (23.53 %)  the  snake  was  killed  and  bought  to  the 
hospital  and  thus  could  be  identified.  The  remaining  76.47 %  sustained  an  
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unknown  or  insect  bite  which  was  later  treated  as  snake  bite  based  on  clinical  
evaluation  and  investigation. Among  the  patients  who  identified  snake  74 %  was  
saw  scaled  viper  bite.  19 % identified  the  snake  as  Russell  Viper  and  two  patients  
who  expired  had  sustained a  Krait  bite. The  cause  of  death  was  coagulopathy. 
 
ANALYSIS  OF  SYSTEMIC  BLEEDING  MANIFESTATIONS  IN  SNAKE 
BITTEN  INDIVIDUALS 
A  total  14  patients  out  of  51  had  systemic  bleeding.  Out  of  them  55 % 
presented  with  hematuria  while  40 %  had  hematemesis  and  5 %  individuals  had 
hemoptysis  or  gum  bleed  or  sub-arachnoid  hemorrhage. 
 
ANALYSIS  OF  THE  TIME  INTERVAL  BETWEEN  SNAKE  BITE  AND 
ONSET  OF  COAGULATION  ABNORMALITY 
The  time  of  onset  of  abnormal  coagulation  was  analyzed  based  on  two  sets 
of  findings.  The  first  was  based  on  the  number  of  patients  who  had  prolonged 
clotting  time  at  the  time  of  admission.  78 %  of  patients  had  abnormal  clotting 
time  at  the  time  of  admission.  The  average  time  period  between  the  bite  and 
hospital  admission  was  8  hours  ranging  from  3  to  13  hours. 
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The  second  group  analysis  has  a  set  of  3  patients  who  had  normal  clotting 
time  at  the  time  of  admission  which  become  abnormal  over  a  period  of  time.  
Two  of  them  developed  it  in  a  period  of  5  hours  and  the  third  patient  by  13 
hours.  Thus  it  was  concluded  that  the  onset  of  abnormal  coagulation  occurred  as 
early  as  3  hours  and  late  as  13  hours  with  a  majority  developing  it  in  a  average 
time  of  8  hours. 
 
All  patients  who  had  prolonged  clotting  time  at  admission  also  had 
prolonged  PT.  One  patient  who  had  initial  normal  clotting  time  and  went  on  to 
develop  abnormal  coagulation  had  prolonged  PT. 
 
CORRELATION  OF  CLINICAL  SEVERITY  WITH  QUANTITATIVE 
COAGULATION  TESTS 
Two  quantitative  tests  namely  platelet  count  and  FDP  were  analyzed  in  
relation  to  clinical  severity. 
 
Platelet  count  was  normal  in  all  patients  belonging  to  grade  I  with  an 
average  of  2.3  lakhs / cu.mm.  The  average  platelet  count  in  grade  II  individuals 
was  1.01  lakhs / cu.mm.  And  grade  III  90,400 / cu.mm.  Thus  individuals  with 
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coagulation  abnormality,  it  did  not  significantly  correlate  with  severity  of 
envenomation. 
 
Blood  FDP  analysis  done  in  patients  of  grade  I  showed  no  reduction, the  
average  level  was  245  mg / dl.  Grade  II  patients  had  an  average  level  of  166 mg / 
dl.  Thus  the  level  of  serum  fibrinogen  was  found  to  be  decreasing  with severity  
of  envenomation 
 
ANALYSIS  OF  THE  TIME  TAKEN  FOR  THE  RETURN  OF 
COAGULATION  PROFILE  TO  NORMAL 
The  time  taken  for  clotting  time  turn  normal  was  analyzed  in  grades  II  and 
III.  For  proper  standardization  a  fixed  regimen  of  ASV  was  used.  Clotting  time 
was  repeated  every  six  hours  and  in  certain  cases  at  more  frequent  intervals.  In 
grade  II  the  average  time  taken  for  the  clotting  time  to  turn  normal  was  8.1 
hours.  The  range  was  from  3  to  21 hours.  In  grade  III  individuals  the  average 
time  taken  for  the  clotting  time  normalization  was  18  hours,  the  range  being  6  to 
24  hours.  The  average  dose  of  ASV  needed  in  grade  II  individuals  was  13.8 (5  to 
40  vials),  in  grade  III  15.5 (10  to  30  vials) 
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The  time  taken  for  the  return  of  PT,  fibrinogen  and  platelet  count  to  
normal  following  ASV  therapy  was  studied  in  four  patients  who  had  normal 
clotting  time  at  admission  though  it  was  initially  prolonged  when  managed  in 
peripheral  hospitals.  PT,  fibrinogen  and  platelet  counts  were  abnormal  in  two 
patients  in  whom  the  test  was  done  at  forty  eight  hours.  In  two  other  patients  in 
whom  the  test  was  done  on  3rd  and  5th   day,  only  fibrinogen  and  platelet  were 
abnormal.  Thus  the  average  time  taken  for  normalization  of  PT  was  found  to  be 
46  hours  and  while  that  taken  for  platelet  count  and  fibrinogen  to  return  to 
normal  was  longer. 
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Table : 4  ANALYSIS  OF  RELATIONSHIP  BETWEEN  THE  TIME  OF  BITE 
INITIATION  OF  THERAPY,  RETURN  OF  COAGULATION  PARAMETERS 
TO  NORMAL  AND  THE  DEVELOPMENT  OF  COMPLICATIONS 
Time  of  onset 
treatment (hours) 
Grade Number  of 
cases 
Average  no. 
of  ASV 
Return  of 
clotting  time 
to  normal 
Number  of  
cases with  
RF  and / or 
shock 
 
0 – 5 
G II 12 14.5 8.8 2* 
G III 2 15 9 1 
 
5 – 10 
G II 8 14.5 8.7 2* 
G III 6 17 11.6 1 
 
10 – 15 
G II 4 10.5 10 0 
G III 2 11.5 11 0 
 
>15 
G II 3 8 7 1 
G III 2 15 20 1 
 
* PATIENTS  ADMITTED  WITH  ESTABLISHED  RENAL  FAILURE 
TREATED  OUTSIDE  TMCH 
It  is  evident  from  analysis  of  the  above  table  4  showed  that  the  time  of  
onset  of therapy  doesn’t  correlate  with  the  development  of  complications  in  
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hospital-treated individuals.  The  incidence  of  renal  failure  and  shock  has  been  
found  to  be  equal in  all  time  periods. 
 
The  return  of  clotting  time  to  normal  following  therapy  with  ASV  also 
didn’t  correlate  with  the  time  period  between  bite  and  onset  of  treatment. 
 
The  only  correlating  factor  was  found  to  be  the  severity  of  envenomation. 
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CORRELATION  OF  COMPARTMENT  SYNDROME  AND  RENAL  
FAILURE 
 
 
total number of patients with compartment syndrome 
 
       17 
 
number of patients undergone fasciotomy 
 
        05 
 
number of patients had renal failure (positive for urine 
myoglobulin)    
 
        12 
 
number of patients undergone peritoneal dialysis 
 
        10  
 
In  our  study  in  5  patients  of  compartment  syndrome  who  had  underwent 
fasciotomy,  the  elevated  renal  parameters  returned  to  normal  within  2  to  4  days. 
Pain  and  swelling  of  the  limbs  subsided  within  2  days  and  the  patients  were 
discharged  early.  One  patient  with  compartment syndrome  who    had  developed  
AKI  with  oliguria  underwent  peritoneal dialysis. It  was  found  that  patients  got  
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admitted  late  after  bite  and  compartment  pressures  in  the  patients were  60 mm Hg  
and  64 mm Hg. 
 
In  12  patients  with  compartment  syndrome  who  had  not  underwent 
fasciotomy,  10  cases  went  for  peritoneal  analysis,  who  had  positive  urine 
myoglobin.  In  all  these  cases  compartment  pressures  were  above  40 mm Hg.  Only 
2  cases  didn’t  go  for  peritoneal  dialysis.  In  these  2  patients  the  compartment 
pressures  were  32 mm Hg  and  34 mm Hg.  These  2  patients  had  prolonged  hospital 
stay. 
 
NEURO PARALYSIS  AND  ITS  TREATMENT  MODALITIES 
6  patients  with  neurotoxic  envenoming  were  treated  with  antisnake  venom  4 
of  them  developed  respiratory  failure.  A  clear  airway  was  maintained  and cuffed  
endotracheal  tube  was  inserted  and  connected  to  ventilator.  
 
Patients  with  neurotoxic  envenoming  remained  fully  conscious  with  intact 
sensation.  Although  artificial  ventilation  was  first  suggested  for  neurotoxic 
envenomination  more  than  100  years  ago,  patients  continue  to  die,  because  they  
did  not  have  access  to  mechanical  ventilation (non-availability  or  non-affordability).  
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Acetylcholine  esterase  have  a  variable  but  potentially useful  effect  in  patients  with  
neurotoxic  envenoming  especially  when  postsynaptic neurotoxin  involved.  Atropine  
sulphate (0.6  mg  for  adults)  was  given  by  intravenous  injection  followed  by  an  
intravenous  injection  of  neostigmine  methyl sulphate (50 - 100 microgram/kg).  This  
does  is  repeated  fourth  hourly  till  the  patient  improves. 
 
ANALYSIS  OF  INCIDENCE  OF  RENAL  FAILURE  IN  RELATION  TO 
ALTERATION  IN  COAGULATION  PROFILE 
 In  total  26  of  the  study  population  developed  renal  failure  of  which  10 % 
belonged  to  grade  I, 56 %  to  grade  II  and  34 %  to  grade  III.  Patients  in  grade  I 
who  developed  renal  failure  had  a  normal  coagulation  profile. 
56 %  of  the  renal  failure  was  from  grade  II,  but  the  important  observation 
was  4  out  of  the  5  patients  who  developed  renal  failure  in  this  group  had 
developed  the  disease  before  hospitalization  in  Thanjavur  Medical  college  hospital. 
They  had  been  treated  with  low  dose  ASV (an  average  of  5  vials)  in  the 
peripheral  centers  before  referral.  Only  one  out  of   twenty   seven   patients  
belonging  to  grade  II developed  renal  failure  during  hospital  therapy.  The  average  
platelet  count  was  1.2 lakhs/cu.mm  and  fibrinogen  level  was  185  mg/dl. 
 
83 
 
In  grade  III,  3  out  of  12  patients (25%)  developed  renal  failure  despite 
hospital  treatment.  The  average  platelet  count  was  85,000/cu.mm  and  fibrinogen 
level  was  124 mg/dl. 
 
All  the  patients  in  grade  III  who  developed  renal  failure  had  hematuria 
which  was  absent  in  grade  I  and  II.  Out  of  26  patients  with  renal  failure,  urine 
myoglobin  was  positive  in  10  cases  who  had  compartment  syndrome. 
 
Thus  in  conclusion,  the  severity  of  envenomation  correlated  with  the 
development  of  renal  failure  in  hospital  treated  individuals.  As  in  case  of  severity, 
FDP  level  and  positive  urine  myoglobin  correlated  well  with  development  of renal  
failure  than  platelet  count 
 
 
RECURRENCE  OF  COAGULATION  ABNORMALITY  AFTER 
NORMALISATION  WITH  ASV  THERAPY 
Only  one  patient  of  the  entire  study  population  showed  a  recurrence  of 
abnormal  coagulation  after  initial  normalization. When   he  was  again  treated  with  
ASV and  clotting  time  returned   to  normal  after  six  hours.  
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ANALYSIS   THE  COMPLICATIONS  OF  ASV  THERAPY 
In  this  study,  12  out  of  51  patient  developed  early  anaphylactic  reaction. 
Clinical  features include  itching,  fever,  tachycardia,  palpitations,  nausea  and  
vomiting. Early reactions was managed  by  0.5  ml  of  0.1 %  adrenaline  
subcutaneous  and  chlorpheneramine  maleate  10 mg  IV. 
  There  was  no  pyrogenic  reaction  and  late  serum  sickness.      
 
ANALYSIS   OF  CARDIOVASCULAR  AND  CEREBROVASCULAR 
MANIFESTATION 
In  this  study  only  6  out  of  51  patients  had  sinus  tachycardia.  All   these  6 
patient  had  neuroparalytic  manifestation.  No  incidence  of  coronary  artery  disease  
or  other  cerebrovascular  disease.  
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                                                 DISCUSSION 
EPIDEMIOLOGICAL  ASPECTS 
The  cauvery  basin,  comprising  the  areas  in  and  around  Thanjavur  is  highly 
fertile  area.  The  primary  occupation  of  the  people  in  this  area,  for  several 
generations,  has  been  agriculture. 
 
The  abundance  of  farmland,  which  is  the  natural  habitat  of  snakes  such  as 
the  viper  meant  that  there  has  been  a  constant  high  incidence  of  snake  bite cases  
over  the  past  several  decades  presenting  to  our  institution,  the commonest  
presentation  has  been  with  coagulation  abnormalities.  So to  highlight  the  clinical  
profile  and  prognosis  of  this  occupational  hazard  and  sensitise  the  primary  care  
physician,  we  decided  to  conduct  a  study  on  the  various  clinical  features  
following  snake bites. 
 
The  incidence  of  snake  bite  and  its  severity  is  well  known  to  increase 
during  the  rainy  season.  In  North  India,  80 %  of  bites  per  annum  occur  between 
May  and  October  while  in  North  Kerala  it  occurs  between  October  and  January. 
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A  total  of  100  cases  were  admitted  following  snake  bite  in  this  period.  Of 
these,  51 %  had  features  of  envenomation.  Of   which  84.32 %  was  hemotoxic, 
11.76 %  was  neurotoxic  and  3.92 %  was  of  mixed  type.  The  bite  of  poisonous 
snakes  produces  envenomation  only  in  50 %  of  cases.  It  is  known  in  India,  out  of 
236  species  of  snakes,  only  50  are  poisonous. 
 
Commonly  encountered  snakes  include  krait,  cobra,  saw  scaled  viper  and 
Russel  viper.2  Taking  these  into  consideration,  the  incidence  of  envenomation  has  
to  be  low  compared  to  the  total  number  of  bites.  Our  study  shows  51 %  of  snake 
bite  victims  had  envenomation  features.  The  high  incidence  may  be  due  to  the  
fact  that  large  number  of  snake  bite  cases  might   have  been  treated  at  local  
hospital  or  referred  here, as  unknown  reptilian  bit  and  treated  accordingly. 
 
As  we  have  mentioned  already,  the  greater  incidence  of  patients  presenting 
with  hemostatic  abnormality  84.32 %  compared  to  neurotoxic  group  11.76 %  may 
be  related  to  the  natural  habitat  of  snakes,  viper  being  the  principal offender 
(farmland  habitat). 
 
Percentage  of  patients  with  bites  in  the  lower  limb  in  our  study  was 
66.66%  and  upper  limb  33.34 %  because  most  of  the  patients  were  farmers  
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working  barefoot  on  their  farms.  This  correlated  with  other  studies  as  shown  by 
wai  in  1974 (lower  limb  bite – 72 %  upper  limb  bites – 25%,  3%  other  parts). 
The  average  duration  of  hospital  stay  in  our  study  was  6  days ( ranges  2  to 
28  days).  The  reason  for  prolonged  hospitalization  included  the  development  of 
complications  like  renal  failure  and  gangrene  secondary  to  compartmental 
syndrome. 
 
CHANGES  OBSERVED  IN  COAGUALTION  PROFILE 
CLOTTING  TIME 
The  study  conducted  by  Reid  reported  100 %  prolongation  of  clotting  time 
in  all  cases  of  definite  envenomation.11  In  Orissa  study,  95 %  had  a  prolonged 
clotting  time.  In  our  study  we  noticed  79 %  prolongation  of  clotting  time.30  6.2 % 
of  these  developed  abnormality  after  admission,  6  to  12  hours  later.  This 
emphasizes  the  fact  that  local  cellulitis  and  lymphadenitis  is  an  important  clue  for 
viper  bite.  Cases  that  had  local  features  but  normal  clotting  time,  also  may  have 
to  be  treated  with  ASV  as  they  may  later  develop  coagulation  abnormality  as  in  
6 %  of  our  cases  or,  may  develop  other  complication  such  as  unheralded  renal 
failure (one  case  in  our  study).  3  patients  had  no  local  features  but  had  prolonged 
clotting  time.  In  conclusion,  clotting  time  prolongation  alone  cannot  be  taken  as  a 
100 %  reliable  indicator  of  hemotoxic  envenomation.  When  clotting  time  was 
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considered  with  local  features,  the  specificity  was  significantly  increased (especially 
viper  bite). 
BLEEDING  TIME 
Only  10 %  showed  prolonged  bleeding  time  in  the  study  conducted  in 
Orissa.  The  incidence  reported  by  Reid  was  5 %. 
 
In  our  study,  none  of  the  patients,  including  those  with  systemic  bleed,  had 
an  abnormal  bleeding  time.  We  infer  that  though  platelet  abnormality  may  be  a 
contributory  factor,  it  is  not  the  major  cause  of  bleeding. 
 
PLATELET  COUNT 
Studies  by  both  Reid  and  Mohapathra (in  Orissa)  showed  as  reduction  in 
platelet  count  in  95 %  and  93 %  respectively.15,32  Saini  et  al  reported  a  10 % 
incidence  of  reduced  platelet  counts.30  We  observed  of  reduced  platelet  counts.  We 
observed  a  reduced  platelet  count  in  all  cases  (average  count – 97,486/cu.mm)  with 
prolonged  clotting  time.  However  there  was  no  significant  correlation  with  
severity.  Even  patients  having  mucosal  bleeds ( hematuria,  hematemesis)  had  only 
moderately  reduced  platelet  counts  (not  sufficient  to  cause  spontaneous  bleeding) 
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and  normal  bleeding  times.  Hence  we  conclude  that  the  effect  of  direct  vasotoxic 
toxin –  hemorrhagin” –  must  be  a  significant  factor  in  causing  mucosal  bleeding.33 
 
PROTHROMBIN  TIME 
Thrombin  time,  prothrombin  time  and  activated  partial  thromboplastin  time 
were  prolonged  in  all  cases  in  the  Orissa  study.34  PT  and  TT  were  prolonged  in  
all cases  in  Reid’s  study.  The  test  was  found  to  be  prolonged  even  in  the  5 %  of 
cases  where  clotting  time  was  normal.  In  our  study  the  test  was  prolonged  in  all 
cases  belonging  to  grades  II  and  III  envenomation (i.e,  those  with  prolonged 
clotting  times).  In  patients  with  normal  clotting  time,  the  test  was  prolonged  in 
only  one  of  the  twelve.  The  significant  finding  was  that  this  cases  was  one  
among  the  three  that  went  on  to  develop  prolongation  of  the  clotting  time  later.  
In  conclusion,  as  with  other  studies,  PT,  has  shown  prolongation  in  all  cases  with 
prolonged  clotting  time,  indicating  that  venom  activates  both  intrinsic  and  extrinsic 
pathway  equally. 
 
              In  patients  with  normal  clotting  times,  the  test  was  prolonged  in  all  cases 
in  the  Orissan  study,  but  in  our  case,  only  one  of  the  patients  belonging  to  this 
category  showed  similar  results,  and  this  patient  went  on  to  develop  clotting 
abnormalities  later.  It  has  been  stated  that  while  the  clotting  time  may  be  normal 
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even  when  clotting  factors  in  the  blood  are  at  1 %  of  normal  amount,  PT  is 
prolonged  below  a  value  of  6 %  of  normal  itself.30  This  suggests  that  the  latter  
tests  detect  hemotoxicity  earlier.  However,  further  large  scale  studies,  with  more 
number  of  patients  are  needed  to  establish  this.  This  average  time  taken  for  the 
normalization  of  these  tests  in  our  study  was  found  to  be  4  hours. 
 
FIBRINOGEN DEGRADATION PRODUCT (FDP): 
Blood  fibrinogen degradation product  was  reduce  in  all  patients  belonging  to  
grades  II  & III  (average  values  166.7 mgs %  and  143.9 mgs %  respectively).  The  
reduction  was proportionate  to  the  severity.  The  other  studies  reported  reduced  
fibrinogen  in  all cases  with  prolonged  clotting  time.15,29 
In  this  study,  we  have  attempted  to  find  out  which  of  disseminated 
intravascular  coagulation  or  primary  fibrinolysis  was  the  underlying  mechanism 
responsible  for  the  coagulation  abnormality. 
 
 Several  international  studies,  including  the  one  by  Reid,  and  an  Indian  
study  by  Mohapathra  et  al  pinpointed  DIC  as  the  primary  mechanism.15,29 
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However,  a  study  by  saint  et  al,  involving  30  cases  of  snake  bite,  reported 
fibrinolysis  as  the  primary  mechanism.35  Primary  fibrinolysis,  a  relatively  rare 
condition,  is  diagnosed  by  the  presence  of  a  combination  of  a   normal  platelet 
count,  early  lysis  of  formed  clots,  marked  elevation  of  FDP,  and  negative  tests  
for  fibrin  monomers (as  tested  by  the  protamine  sulphate  test).  However,  these 
findings  were  absent  in  our  patients  and  hence  we  favor  DIC  as  the  primary 
mechanism.  Furthermore,  post  mortem  studies  of  the  two  cases  who  died  with 
bleeding  manifestations  revealed  changes  suggestive  of  DIC. 
 
To  summarize  the  changes  in   the  coagulation  profile,  it  is  found  that  snake 
activates  both  intrinsic  and  extrinsic  pathway  equally,  with  DIC  as  the  main  factor 
responsible  for  bleeding.  This  seems  to  suggests  a  role  for  the  usage  of  heparin  
in  the  early  phase  of  therapy.  Platelets  abnormalities  may  be  a  contributory 
mechanism,  but  are  not  primarily  responsible.  Spontaneous  mucosal  bleeds  
observed  may  be  due  to  directly  vasotoxic  hemorrhagin. 
 
COMMON  SNAKEBITES  PRESENTING  AS  BLEEDING  DIATHESIS: 
      Only  27.45 %  of  our  patients  could  identify  the  snakes  they  had  been 
bitten,  of  which  70 %  were  Saw-scaled  viper  bite,  Russel  and  8 %  Krait.  Similar 
distributions  have  been  reported  by  other  workers.11  The  majority  of  victims 
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(72.55%)  could  not  identify  the  snake  they  were  bitten  by  and  hence  as  suggested 
by  Reid,  we  would  like  to  emphasize  that  the  treatment  should  be  based  more  on 
the  clinical  presentation  than  on  the  identification  of  the  snake.15 
 
COMMON  FORMS  OF  SYSTEMIC  BLEEDING: 
      In  this  study,  52 %   of  patients  with  systemic  bleeding  had  hematuria, 
405  hematemesis,  and  the  rest  had  hemoptysis  or  gum  bleeding.  Other  common 
forms  cited  in  literature  are  hemoptysis (Reid),  and  hematuria  (Virmani  et  al  from 
Kashmir).36 
 
ONSET  OF  COAGULATION  ABNORMALITY: 
      Practically,  it  is  quite  difficult  to  predict  the  exact  time  of  onset  of 
coagulation  abnormality  in  a  given  case.  As  discussed  earlier,  the  PT  may  be 
prolonged  even  before  overt  prolongation  of  the  clotting  time. 
 
We  used  those  patients  who  developed  clotting  abnormalities  after  admission 
to  calculate  the  shortest  (3  hours)  and  the  longest (13  hours)  interval  between  the 
bite  and  then  onset  of  clotting  abnormality. 
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The  average  interval,  calculated  by  including  the  data  from  patients  with 
bleeding  diathesis  at  admission,  was  7.15  hours. 
 
QUANTITATIVE  TEST  IN  RELATION  TO  CLINICAL  SEVERITY: 
 The  FDP  level  showed  some  correlation  with  clinical  severity,  with the  
level  being  166 mg %  in  grade  II  and  143  mg %  in  grade  III  patients.  As  in other  
studies,  none  of  other  tests  showed  any  correlation,  including  platelets  count. 
 
TIME  TAKEN  FOR  NORMALISATION  OF  CLOTTING  TIME: 
    Reid  reported  that  the  clotting  time  returned  to  normal  in  9  hours  with 
specific  antiserum,  and  24  hours  with  polyvalent  serum  alone  were  used,  and  we 
found  the  average  time  for  normalization  to  be  7.9  hours  in  grade  II  and  18  
hours  in  grade  III  envenomation.  The  time  taken  for  PT  to  return  to  normal  was 
48  hours,  similar  to  the  finding  in  the  Orissan  study.  For  FDP  and  platelets counts  
to  return  to  normal,  it  took  3  to  4  days  approximately. 
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RELATIONSHIP  BETWEEN  TIME  OF  STARTING  TREATMENT, 
DEVELOPMENT  OF  COMPLICATIONS,  AND  NORMALISATION  OF 
CLOTTING  TIME: 
         It  was  Reid  who  originally  proved   that  the  coagulation  profile  
returned  to  normal  rapidly  with  therapy,  regardless  of  the  time  elapsed  before  the 
start  of  treatment.11  The  results  of  our  study  also  suggest  that  both  the  probability 
of  complications  and  the  time  taken  to  achieve  normalization  of  coagulation  both 
depended  on  the  severity  if  the  bite,  and  not  the  time  elapsed  before  starting  of 
treatment.  On  this  basis  and  in  1968,  we  concluded  that  ASV  can  be  effective 
even  if  given  late  and  there  is  no  time  limit  for  starting  ASV  therapy. 
 
RENAL  FAILURE  AND  ITS  RELATIONSHIP  OF  CLOTTING 
ABNORMALITIES: 
Our  study  showed  the  incidence  of  renal  failure (developing  in  hospital) to  
be  26 %.  The  distribution  according  to  grades  showed  an  increasing  incidence in  
the  severe  grades  from  I,  II,  and  III (20%,  20%  and  60%)  respectively.  This points  
to  the  direct  role  for  coagulation  abnormality  in  the  pathogenesis  of  renal failure.  
4  cases  were  admitted  in  established  renal  failure,  after  receiving  treatment outside.  
One  patient  belonging  to  grade  I  also  develop  renal  failure,  suggesting  a direct  
effect  of  snake  venom  on  the  kidney  was  operational  in  this  case.  Among the  
95 
 
quantitative  tests,  only  myoglobinuria  fibrinogen  depletion  and  low  platelets counts  
correlated  with  the  development  of  renal  failure. 
 
RECURRENCE  OF  CLOTTING  ABNORMALITY  AFTER  INITIAL 
NORMALISATION: 
Such  an  occurrence  was  seen  only  in  one  out  of  our  50  patients.  This 
phenomenon  according  to  Reid  may  occur  in  those  cases  where  the  initial  doses 
of  ASV  were  inadequate.  Even  our  single  patients  was  previously  treated  in  the 
peripheral  center  and  probably  the  initial  dose,  given  there,  was  inadequate.11 
Therefore  the  results  of  our  study  do  not  recommend  the  continuance  of  ASV 
therapy  following  the  normalization  of  clotting  time,  provided  an  adequate dose 
(according  to  grade  of  envenomation) has  been  given  initially. 
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CONCLUSIONS 
1. Hemotoxic  envenomation  was  the  commonest  form  of  snake  bite  poisoning  seen 
in  this  study. 
2. Saw-scaled  viper  was  the  commonest  snake  causing  coagulation  abnormality 
while  Krait  was  the  most   poisonous  (in  terms  of  mortality). 
3. Onset  of  coagulation  abnormality  occurred  as  early  as  3  hours  and  as  late  as  
13  hours  following  snake  bite. So  all  patients  with  history  of  snake  bite  should  be  
under  medical  supervision  for  at  least  24  hours. 
4. In  the  diagnosis  of  Hemotoxic  envenomation  the  presence  of  local  signs  plus  a 
prolonged  clotting  time  had  a  sensitivity  of  100 %. 
5. Prothrombin  time  appears  to  be   prolonged  earlier  than  clotting  time  needs 
further  confirmation. 
6. Among  the  quantitative  coagulation  tests  only  fibrinogen  level  was  correlated 
with  the  severity  of  envenomation  compared  to  platelet  count. 
7. The  time  interval  between  the  bite  and  initiation  of  treatment  was  not  found  to 
be  related  to  time  taken  for  normalization  of  the  coagulation  abnormality  or  to  the 
development  of  complication  in  this  study. 
8. Following  ASV   therapy,  the  time  taken  for  normalization  of  clotting  time  was 
found  to  be  around  8  hours  in  Grade  II  and  18  hours  in  Grade  III  individuals. 
97 
 
9. Direct  effect  of  venom  on  the  kidney  was  also  found  to  play  a  role  along  with 
disseminated  intravascular  coagulation  and  pigment  Nephropathy  in  the  causation  
of  renal  failure. 
10. This  Study  shows  that  early  and  adequate  fasciotomy  reduces  the  necrosis  of 
the  bitten  limb  by  100 %  and  acute  renal  failure  by  83 %. 
11. Since  majority  of  snake  bites  are in  lowerlimbs,  farmers  and  labourers  may  be  
advised  to  wear  shoes  during  work. 
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ABBREVIATIONS 
S.NO  - serial number                                          M  -  Male                            X  -  sex 
SI  -  site                                                                  F  -  Female                          K  -  Kraitt 
IP  - In Patient number                                        U   -  Unknown                   Grd  -  Grade 
DOA  - Date of admission                                   LF  -  Left Foot                    G1  -  Grade 1 
R  - Russell’s viper                                                RF  -  Right Foot                 G2  -  Grade 2 
HMTU  -  Hematuria                                            LA  -  Left Arm                    G3  -  Grade 3 
Gu  -  Gum Bleed                                                  RA  -  Right Arm                 ID  -  In Definite 
Syb  -  Systemic Bleed                                         HMTS  -  Hemetemesis 
S  -  Saw scaled viper                                           Assf  -  Associated Features 
Co  -  Clinical outcome                                        A  -  Average 
G1-2  -  Initial G1 after admission G2               G  -  Good 
G2-1  - Initial G2 after admission G1                E -  Expired 
Plt  -  Platelet count in lakhs 
Bt  -  bleeding time in minutes 
Ct  -  Clotting time in minutes 
Pt  -  Pro thrombin in seconds 
Bni  -  Bite needle interval in hours 
Aa  -  Number of ASV given after clotting normalisation 
Ab  -  Number of ASV given before clotting normalisation 
Nt  -  Normalisation of clotting time in hours after ASV therapy 
Fib  -  Fibrinogen mg% 
UD  -  Urine Deposits 
Cho  -  Cholesterol  mg% 
UMG  -  Urine myoglobulin 
CS  -  Compartment Syndrome         
 
